News By Tag
News By Place
J. David Enloe, Jr. Appointed as President and Chief Executive Officer of Ajinomoto Althea, Inc
Executive search firm SANFORD ROSE ASSOCIATES® – TOFT GROUP, is proud to announce another successful placement.
Mr. Enloe is a dynamic business leader with 20+ years of biotechnology executive management experience. His background includes broad skill sets in leadership, financial management, manufacturing and contractual negotiations within both small startups and multi-national corporations.
Mr. Enloe joins Ajinomoto Althea, Inc., after serving most recently as Head of the Viral Therapeutics Business Unit at Lonza AG. In 2009, Mr. Enloe formed Vivante GMP Solutions, Inc., and was later responsible for executing the sale of the company to Lonza AG. This union formed a new business unit which he has managed since 2010. Prior to this he was President and CEO of Introgen Technical Services, Inc., which later became the basis for Vivante.
Robin Toft, President and CEO of Sanford Rose Associates® – Toft Group said: “We are exceedingly proud to have recommended Mr. Enloe to Ajinomoto Althea Inc., and congratulate him on his new role as President and CEO. We believe he will make an outstanding contribution to the continued development of the company’s business. We look forward to the continued success of both Mr. Enloe and our client, Ajinomoto Althea Inc.”
“I am thrilled about the growth strategy Ajinomoto Althea Inc. is pursuing, and am very excited to lead the company as President and Chief Executive Officer,” said Mr. Enloe. “All of my past experiences to date have positioned me for this incredible role. Althea’
Ajinomoto Althea Inc., (www.altheatech.com)
Sanford Rose Associates® - Toft Group (www.sanfordrose.net/
Robin Toft, President and CEO, Sanford Rose Associates – Toft Group at (928) 837-5800.